Frequently Asked Questions (FAQ)
-
What is Target 2035?
-
Target 2035 is currently an informal alliance of international biomedical scientists from the public and private sectors. It is not a funding body. Our aim is to develop and to apply new technologies to create chemogenomic libraries, chemical and/or biological probes for the entire human proteome using open science by the year 2035.
-
-
Why create chemical probes to every protein?
-
With the human genome mapped it is now important to generate the tools that will allow the community to determine the functions and disease relevance of every human gene. Among the most impactful research tools are chemical and biological probes (Edwards, A.M. et al. Too many roads not taken Nature (2011), https://doi.org/10.1038/470163a. These reagents will catalyze research, lead to the validation of novel therapeutic targets, and ultimately the discovery of better medicines. (Carter, A.J. et al. Target 2035: probing the human proteome, Drug Discov Today (2019), doi.org/10.1016/j.drudis.2019.06.020).
-
-
Who is part of Target 2035?
-
Target 2035 comprises researchers world-wide and is coordinated by the SGC (www.thesgc.org). It includes participants from academia and industry.
-
-
What are chemical probes?
-
A chemical probe is a compound that selectively modulates the activity of a single protein (or a small group of closely related proteins) in cells at reasonable concentrations (< 1 micromolar), i.e., it is potent, selective and cell active.
-
-
What are biological probes?
-
Biological probes are monoclonal antibodies and/or other macromolecular affinity reagents shown to be potent and that selectively modulate the activity of a protein target.
-
-
What is the dark proteome/ dark genome?
-
Almost 20 years after the human genome was sequenced, many of the genes linked to disease phenotypes or those associated with specific disease traits by genome-wide association studies remain severely understudied: the so-called ‘dark genome’. (https://doi.org/10.1038/470163a, https://doi.org/10.1016/j.drudis.2019.06.020, https://doi.org/10.1038/nrd.2018.52 )
-